139 related articles for article (PubMed ID: 1553631)
1. [Interindividual differences in the reaction to drugs and poisons].
Meyer UA
Ther Umsch; 1992 Feb; 49(2):97-101. PubMed ID: 1553631
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM
Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
[TBL] [Abstract][Full Text] [Related]
3. [Clinically significant inherited differences in the mode of action of drugs].
Meyer UA; Meier PJ
Schweiz Med Wochenschr; 1982 May; 112(19):666-9. PubMed ID: 7100864
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic drug metabolism.
Relling MV
Clin Pharm; 1989 Dec; 8(12):852-63. PubMed ID: 2689060
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics of oxidation reactions of drugs].
Jacqz-Aigrain E
Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266
[TBL] [Abstract][Full Text] [Related]
6. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenetics and its importance in the clinical].
Lares-Asseff I; Trujillo-Jiménez F
Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
9. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic drug oxidation in humans.
Eichelbaum M
Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
[TBL] [Abstract][Full Text] [Related]
11. [Role of pharmacogenetics in psychopharmacotherapy].
Gram LF
Encephale; 1991; 17 Spec No 1():123-5. PubMed ID: 1864259
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].
Baumann P
Encephale; 1986; 12(4):143-8. PubMed ID: 3792273
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic polymorphism of drug metabolism.
Paxton JW
N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
[No Abstract] [Full Text] [Related]
14. [Stability and/or variability of the expression of genetic polymorphism of hydroxylation and acetylation in patients with various pathologies and under various treatments].
Bechtel P; Joanne C; Bechtel Y; Grandmottet M; Jounet JM
Ann Biol Clin (Paris); 1986; 44(4):361-7. PubMed ID: 3538951
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetics: pharmacokinetics and clinical implications].
Blardi P
Recenti Prog Med; 1997 Jan; 88(1):46-55. PubMed ID: 9102716
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of antipsychoatics.
Ozaki N
Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
[TBL] [Abstract][Full Text] [Related]
18. [Knowledge about metabolic capacity is important in drug therapy].
Alván G; Dahl ML
Lakartidningen; 1992 Feb; 89(6):382, 387-90. PubMed ID: 1738265
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in reactions to drugs and xenobiotics. Therapy.
Evans DA
Prog Clin Biol Res; 1986; 214():491-526. PubMed ID: 3523517
[No Abstract] [Full Text] [Related]
20. The non-human primate: a possible model for human genetically determined polymorphisms in oxidative drug metabolism.
Jacqz E; Billante C; Moysan F; Mathieu H
Mol Pharmacol; 1988 Aug; 34(2):215-7. PubMed ID: 3412323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
